Safety and efficacy of astegolimab for COPD with frequent exacerbations regardless of baseline blood eosinophil counts (ALIENTO and ARNASA): randomised, double-blind, placebo-controlled, phase 2b and 3 trials.
Saved in:
| Title: | Safety and efficacy of astegolimab for COPD with frequent exacerbations regardless of baseline blood eosinophil counts (ALIENTO and ARNASA): randomised, double-blind, placebo-controlled, phase 2b and 3 trials. |
|---|---|
| Authors: | Papi A; Pulmonary Division, University of Ferrara, St Anna University Hospital, Ferrara, Italy. Electronic address: ppa@unife.it., Greening NJ; Institute for Lung Health, Department of Respiratory Sciences, University of Leicester, Leicester, UK., Bhatt SP; Division of Pulmonary, Allergy, and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Roche N; Université Paris Cité, APHP Centre, Hôpital et Institut Cochin, Paris, France., Celli B; Mass General Brigham Hospital, Harvard University Medical School, Boston, MA, USA., Wedzicha JA; National Heart and Lung Institute, Imperial College London, London, UK., Agustí À; University of Barcelona, Barcelona, Spain; Respiratory Institute, Hospital Clinic, Barcelona, Spain; FCRB-IDIBAPS, Barcelona, Spain; CIBER Enfermedades Respiratorias, ISCIII, Spain., Tal-Singer R; Global Allergy & Airways Patient Platform, Vienna, Austria., Han MK; University of Michigan, Ann Arbor, MI, USA., Janssens W; Department of Chronic Diseases and Metabolism (CHROMETA), University Hospital Leuven, KU Leuven, Belgium., Hanania NA; Section of Pulmonary and Critical Care Medicine, Baylor College of Medicine, Houston, TX, USA., Nair P; Department of Medicine, McMaster University, Hamilton, ON, Canada; Research Institute of St Joe's Hamilton, St Joseph's Healthcare Hamilton, Hamilton, ON, Canada., Bremner P; University of Notre Dame, Fremantle, WA, Australia., Porpodis K; Pulmonology Department, G Papanikolaou Hospital, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece., Shibata Y; Fukushima Medical University, Fukushima, Japan., Korn S; IKF Pneumologie Mainz, Mainz, Germany; Thoraxklinik Heidelberg, Heidelberg, Germany., Yang T; China-Japan Friendship Hospital, Beijing, China., Gordon O; Roche Products, Welwyn Garden City, Hertfordshire, UK., Saenz R; Genentech, South San Francisco, CA, USA., Ng J; Genentech, South San Francisco, CA, USA., Cheung DS; Genentech, South San Francisco, CA, USA., Devine J; Genentech, South San Francisco, CA, USA., Grimbaldeston MA; Genentech, South San Francisco, CA, USA., Zhang W; Genentech, South San Francisco, CA, USA., Yang X; Genentech, South San Francisco, CA, USA., Mohan D; Genentech, South San Francisco, CA, USA., Vogelmeier CF; Department of Medicine, Pulmonary, Critical Care and Sleep Medicine, Philipps University of Marburg, German Center for Lung Research (DZL), Marburg, Germany., Brightling CE; Institute for Lung Health, Department of Respiratory Sciences, University of Leicester, Leicester, UK. |
| Corporate Authors: | ALIENTO and ARNASA investigators |
| Source: | Lancet (London, England) [Lancet] 2026 May 23; Vol. 407 (10543), pp. 2027-2039. Date of Electronic Publication: 2026 May 18. |
| Publication Type: | Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42150581 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Safety and efficacy of astegolimab for COPD with frequent exacerbations regardless of baseline blood eosinophil counts (ALIENTO and ARNASA): randomised, double-blind, placebo-controlled, phase 2b and 3 trials. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Papi+A%22">Papi A</searchLink>; Pulmonary Division, University of Ferrara, St Anna University Hospital, Ferrara, Italy. Electronic address: ppa@unife.it.<br /><searchLink fieldCode="AU" term="%22Greening+NJ%22">Greening NJ</searchLink>; Institute for Lung Health, Department of Respiratory Sciences, University of Leicester, Leicester, UK.<br /><searchLink fieldCode="AU" term="%22Bhatt+SP%22">Bhatt SP</searchLink>; Division of Pulmonary, Allergy, and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Roche+N%22">Roche N</searchLink>; Université Paris Cité, APHP Centre, Hôpital et Institut Cochin, Paris, France.<br /><searchLink fieldCode="AU" term="%22Celli+B%22">Celli B</searchLink>; Mass General Brigham Hospital, Harvard University Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Wedzicha+JA%22">Wedzicha JA</searchLink>; National Heart and Lung Institute, Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Agustí+À%22">Agustí À</searchLink>; University of Barcelona, Barcelona, Spain; Respiratory Institute, Hospital Clinic, Barcelona, Spain; FCRB-IDIBAPS, Barcelona, Spain; CIBER Enfermedades Respiratorias, ISCIII, Spain.<br /><searchLink fieldCode="AU" term="%22Tal-Singer+R%22">Tal-Singer R</searchLink>; Global Allergy & Airways Patient Platform, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Han+MK%22">Han MK</searchLink>; University of Michigan, Ann Arbor, MI, USA.<br /><searchLink fieldCode="AU" term="%22Janssens+W%22">Janssens W</searchLink>; Department of Chronic Diseases and Metabolism (CHROMETA), University Hospital Leuven, KU Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Hanania+NA%22">Hanania NA</searchLink>; Section of Pulmonary and Critical Care Medicine, Baylor College of Medicine, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Nair+P%22">Nair P</searchLink>; Department of Medicine, McMaster University, Hamilton, ON, Canada; Research Institute of St Joe's Hamilton, St Joseph's Healthcare Hamilton, Hamilton, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Bremner+P%22">Bremner P</searchLink>; University of Notre Dame, Fremantle, WA, Australia.<br /><searchLink fieldCode="AU" term="%22Porpodis+K%22">Porpodis K</searchLink>; Pulmonology Department, G Papanikolaou Hospital, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.<br /><searchLink fieldCode="AU" term="%22Shibata+Y%22">Shibata Y</searchLink>; Fukushima Medical University, Fukushima, Japan.<br /><searchLink fieldCode="AU" term="%22Korn+S%22">Korn S</searchLink>; IKF Pneumologie Mainz, Mainz, Germany; Thoraxklinik Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Yang+T%22">Yang T</searchLink>; China-Japan Friendship Hospital, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Gordon+O%22">Gordon O</searchLink>; Roche Products, Welwyn Garden City, Hertfordshire, UK.<br /><searchLink fieldCode="AU" term="%22Saenz+R%22">Saenz R</searchLink>; Genentech, South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Ng+J%22">Ng J</searchLink>; Genentech, South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Cheung+DS%22">Cheung DS</searchLink>; Genentech, South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Devine+J%22">Devine J</searchLink>; Genentech, South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Grimbaldeston+MA%22">Grimbaldeston MA</searchLink>; Genentech, South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+W%22">Zhang W</searchLink>; Genentech, South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Yang+X%22">Yang X</searchLink>; Genentech, South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Mohan+D%22">Mohan D</searchLink>; Genentech, South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Vogelmeier+CF%22">Vogelmeier CF</searchLink>; Department of Medicine, Pulmonary, Critical Care and Sleep Medicine, Philipps University of Marburg, German Center for Lung Research (DZL), Marburg, Germany.<br /><searchLink fieldCode="AU" term="%22Brightling+CE%22">Brightling CE</searchLink>; Institute for Lung Health, Department of Respiratory Sciences, University of Leicester, Leicester, UK. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22ALIENTO+and+ARNASA+investigators%22">ALIENTO and ARNASA investigators</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%222985213R%22">Lancet (London, England)</searchLink> [Lancet] 2026 May 23; Vol. 407 (10543), pp. 2027-2039. <i>Date of Electronic Publication: </i>2026 May 18. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>2985213R <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1474-547X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201406736%22">01406736 </searchLink><i>NLM ISO Abbreviation: </i>Lancet <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42150581 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/S0140-6736(26)00637-9 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2027 Titles: – TitleFull: Safety and efficacy of astegolimab for COPD with frequent exacerbations regardless of baseline blood eosinophil counts (ALIENTO and ARNASA): randomised, double-blind, placebo-controlled, phase 2b and 3 trials. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Papi A – PersonEntity: Name: NameFull: Greening NJ – PersonEntity: Name: NameFull: Bhatt SP – PersonEntity: Name: NameFull: Roche N – PersonEntity: Name: NameFull: Celli B – PersonEntity: Name: NameFull: Wedzicha JA – PersonEntity: Name: NameFull: Agustí À – PersonEntity: Name: NameFull: Tal-Singer R – PersonEntity: Name: NameFull: Han MK – PersonEntity: Name: NameFull: Janssens W – PersonEntity: Name: NameFull: Hanania NA – PersonEntity: Name: NameFull: Nair P – PersonEntity: Name: NameFull: Bremner P – PersonEntity: Name: NameFull: Porpodis K – PersonEntity: Name: NameFull: Shibata Y – PersonEntity: Name: NameFull: Korn S – PersonEntity: Name: NameFull: Yang T – PersonEntity: Name: NameFull: Gordon O – PersonEntity: Name: NameFull: Saenz R – PersonEntity: Name: NameFull: Ng J – PersonEntity: Name: NameFull: Cheung DS – PersonEntity: Name: NameFull: Devine J – PersonEntity: Name: NameFull: Grimbaldeston MA – PersonEntity: Name: NameFull: Zhang W – PersonEntity: Name: NameFull: Yang X – PersonEntity: Name: NameFull: Mohan D – PersonEntity: Name: NameFull: Vogelmeier CF – PersonEntity: Name: NameFull: Brightling CE IsPartOfRelationships: – BibEntity: Dates: – D: 23 M: 05 Text: 2026 May 23 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1474-547X Numbering: – Type: volume Value: 407 – Type: issue Value: 10543 Titles: – TitleFull: Lancet (London, England) Type: main |
| ResultId | 1 |